Company Profile
CR Sanjiu (Youyang) Pharmaceutical Co., Ltd. formerly known as Chongqing Wuling Mountain Pharmaceutical Factory, established in December 1986, is now a subsidiary of Huaren Sanjiu Kunyao Group Co., Ltd. The production and operation land covers 251 mu, with a registered capital of 75.5 million yuan. It has successively won the "National High-tech Enterprise", "Chongqing Agricultural Industrialization Leading Enterprise", "Chongqing Contract-Honoring and Credit-Keeping Enterprise", "Chongqing Civilized Unit" 、 " Chongqing Specialized, Refined, and Innovative Enterprise ” and other honorary titles.
The company mainly produces artemisinin and its series of derivatives, and Maqin cough syrup 、 Artemisia annua health products production and sales. Currently, there are artemisinin, artesunate, dihydroartemisinin, Maqin cough syrup 、 artesunate 5 production lines.
The company is currently a domestic and international artemisinin industry chain with a relatively complete range of raw material medicine production bases. In cooperation with Southwest University, a joint artemisinin high-yield and high-quality variety cultivation center has been established, and artemisinin GAP planting base of over 20,000 mu has been built for many years. Artemisinin production has passed the national pharmaceutical GMP certification, and the production quality control system has been on-site inspected and approved by the World Health Organization. Dihydroartemisinin and artesunate have passed the on-site PQ certification inspection of the World Health Organization.
The company adheres to the advanced corporate culture concept of Kunyao Group, with " Great medicine, thick virtue 、 Suffering and embracing " as its mission, constantly innovating management concepts and marketing models, strengthening strategic cooperation with customers, sharing resources, achieving mutual benefit and win-win results, and striving to become an innovative pharmaceutical enterprise with sustained competitiveness. It supports the upgrading and development of the traditional Chinese medicine industry, continuously promotes the inheritance and innovation of traditional Chinese medicine, and uses performance to practice the responsibility and responsibility of state-owned enterprises.